跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEPO-PROVERA medroxyprogesterone acetate 150 mg/1 mL suspension for injection pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
DEPO-PROVERA medroxyprogesterone acetate 150 mg/1 mL suspension for injection pre-filled syringe
Approved
STANDARD
DEPO-PROVERA medroxyprogesterone acetate 150 mg/1 mL suspension for injection pre-filled syringe
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
5732ef2e6c732010
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
5732ef2e6c732010
Product Name
DEPO-PROVERA medroxyprogesterone acetate 150 mg/1 mL suspension for injection pre-filled syringe
Artg Id
401610
Artg Name
DEPO-PROVERA medroxyprogesterone acetate 150 mg/1 mL suspension for injection pre-filled syringe
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
2023-05-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/3bc149e17f0c1cf00f220ccba84baa03.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/b9b9784e53ac43a4fcb48fb2b1d9cc24.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
5732ef2e6c732010
Type
Standard
Back to TGA Approvals